Global Cancer Therapy and Testing Market Research Report 2026(Status and Outlook)

May 2026 | 153 pages | ID: G4EEF7C3A24AEN
Bosson Research

Abstracts

Cancer Therapy and TestingThe cancer therapy and testing market has been witnessing significant growth over the years and is expected to continue expanding in the future. Several factors contribute to this market growth, including the increasing incidence of cancer globally, advancements in diagnostic technologies, personalized medicine approaches, and a growing emphasis on early detection and targeted therapies.

The global Cancer Therapy and Testing market size was estimated at USD 885040.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 13.10% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Cancer Therapy and Testing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Cancer Therapy and Testing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Cancer Therapy and Testing market.

Global Cancer Therapy and Testing Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

• Invitae
• Foundation Medicine
• Guardant Health
• Illumina
• Sysmex
• Abingdon Health
• Sophia
• NanoEntek
• BGI
• Diagnosis
• Exact Sciences
• AstraZeneca
• Bayer AG
• Johnson & Johnson
• Pfizer Inc.

Market Segmentation (by Type)

• Cancer Detection
• Cancer Treatment

Market Segmentation (by Application)

• Lung Cancer
• Rectal Cancer
• Breast Cancer
• Other

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Cancer Therapy and Testing Market

Overview of the regional outlook of the Cancer Therapy and Testing Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cancer Therapy and Testing Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Cancer Therapy and Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Cancer Therapy and Testing
1.2 Key Market Segments
  1.2.1 Cancer Therapy and Testing Segment by Type
  1.2.2 Cancer Therapy and Testing Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 CANCER THERAPY AND TESTING MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Cancer Therapy and Testing Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global Cancer Therapy and Testing Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 CANCER THERAPY AND TESTING MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Cancer Therapy and Testing Product Life Cycle
3.3 Global Cancer Therapy and Testing Sales by Manufacturers (2020-2025)
3.4 Global Cancer Therapy and Testing Revenue Market Share by Manufacturers (2020-2025)
3.5 Cancer Therapy and Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Cancer Therapy and Testing Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Cancer Therapy and Testing Market Competitive Situation and Trends
  3.8.1 Cancer Therapy and Testing Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Cancer Therapy and Testing Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 CANCER THERAPY AND TESTING INDUSTRY CHAIN ANALYSIS

4.1 Cancer Therapy and Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF CANCER THERAPY AND TESTING MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Cancer Therapy and Testing Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy – April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Cancer Therapy and Testing Market
5.7 ESG Ratings of Leading Companies

6 CANCER THERAPY AND TESTING MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cancer Therapy and Testing Sales Market Share by Type (2020-2025)
6.3 Global Cancer Therapy and Testing Market Size by Type (2020-2025)
6.4 Global Cancer Therapy and Testing Price by Type (2020-2025)

7 CANCER THERAPY AND TESTING MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cancer Therapy and Testing Market Sales by Application (2020-2025)
7.3 Global Cancer Therapy and Testing Market Size (M USD) by Application (2020-2025)
7.4 Global Cancer Therapy and Testing Sales Growth Rate by Application (2020-2025)

8 CANCER THERAPY AND TESTING MARKET SALES BY REGION

8.1 Global Cancer Therapy and Testing Sales by Region
  8.1.1 Global Cancer Therapy and Testing Sales by Region
  8.1.2 Global Cancer Therapy and Testing Sales Market Share by Region
8.2 Global Cancer Therapy and Testing Market Size by Region
  8.2.1 Global Cancer Therapy and Testing Market Size by Region
  8.2.2 Global Cancer Therapy and Testing Market Size by Region
8.3 North America
  8.3.1 North America Cancer Therapy and Testing Sales by Country
  8.3.2 North America Cancer Therapy and Testing Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Cancer Therapy and Testing Sales by Country
  8.4.2 Europe Cancer Therapy and Testing Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Cancer Therapy and Testing Sales by Region
  8.5.2 Asia Pacific Cancer Therapy and Testing Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Cancer Therapy and Testing Sales by Country
  8.6.2 South America Cancer Therapy and Testing Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Cancer Therapy and Testing Sales by Region
  8.7.2 Middle East and Africa Cancer Therapy and Testing Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 CANCER THERAPY AND TESTING MARKET PRODUCTION BY REGION

9.1 Global Production of Cancer Therapy and Testing by Region(2020-2025)
9.2 Global Cancer Therapy and Testing Revenue Market Share by Region (2020-2025)
9.3 Global Cancer Therapy and Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Cancer Therapy and Testing Production
  9.4.1 North America Cancer Therapy and Testing Production Growth Rate (2020-2025)
  9.4.2 North America Cancer Therapy and Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Cancer Therapy and Testing Production
  9.5.1 Europe Cancer Therapy and Testing Production Growth Rate (2020-2025)
  9.5.2 Europe Cancer Therapy and Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Cancer Therapy and Testing Production (2020-2025)
  9.6.1 Japan Cancer Therapy and Testing Production Growth Rate (2020-2025)
  9.6.2 Japan Cancer Therapy and Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Cancer Therapy and Testing Production (2020-2025)
  9.7.1 China Cancer Therapy and Testing Production Growth Rate (2020-2025)
  9.7.2 China Cancer Therapy and Testing Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Invitae
  10.1.1 Invitae Basic Information
  10.1.2 Invitae Cancer Therapy and Testing Product Overview
  10.1.3 Invitae Cancer Therapy and Testing Product Market Performance
  10.1.4 Invitae Business Overview
  10.1.5 Invitae SWOT Analysis
  10.1.6 Invitae Recent Developments
10.2 Foundation Medicine
  10.2.1 Foundation Medicine Basic Information
  10.2.2 Foundation Medicine Cancer Therapy and Testing Product Overview
  10.2.3 Foundation Medicine Cancer Therapy and Testing Product Market Performance
  10.2.4 Foundation Medicine Business Overview
  10.2.5 Foundation Medicine SWOT Analysis
  10.2.6 Foundation Medicine Recent Developments
10.3 Guardant Health
  10.3.1 Guardant Health Basic Information
  10.3.2 Guardant Health Cancer Therapy and Testing Product Overview
  10.3.3 Guardant Health Cancer Therapy and Testing Product Market Performance
  10.3.4 Guardant Health Business Overview
  10.3.5 Guardant Health SWOT Analysis
  10.3.6 Guardant Health Recent Developments
10.4 Illumina
  10.4.1 Illumina Basic Information
  10.4.2 Illumina Cancer Therapy and Testing Product Overview
  10.4.3 Illumina Cancer Therapy and Testing Product Market Performance
  10.4.4 Illumina Business Overview
  10.4.5 Illumina Recent Developments
10.5 Sysmex
  10.5.1 Sysmex Basic Information
  10.5.2 Sysmex Cancer Therapy and Testing Product Overview
  10.5.3 Sysmex Cancer Therapy and Testing Product Market Performance
  10.5.4 Sysmex Business Overview
  10.5.5 Sysmex Recent Developments
10.6 Abingdon Health
  10.6.1 Abingdon Health Basic Information
  10.6.2 Abingdon Health Cancer Therapy and Testing Product Overview
  10.6.3 Abingdon Health Cancer Therapy and Testing Product Market Performance
  10.6.4 Abingdon Health Business Overview
  10.6.5 Abingdon Health Recent Developments
10.7 Sophia
  10.7.1 Sophia Basic Information
  10.7.2 Sophia Cancer Therapy and Testing Product Overview
  10.7.3 Sophia Cancer Therapy and Testing Product Market Performance
  10.7.4 Sophia Business Overview
  10.7.5 Sophia Recent Developments
10.8 NanoEntek
  10.8.1 NanoEntek Basic Information
  10.8.2 NanoEntek Cancer Therapy and Testing Product Overview
  10.8.3 NanoEntek Cancer Therapy and Testing Product Market Performance
  10.8.4 NanoEntek Business Overview
  10.8.5 NanoEntek Recent Developments
10.9 BGI
  10.9.1 BGI Basic Information
  10.9.2 BGI Cancer Therapy and Testing Product Overview
  10.9.3 BGI Cancer Therapy and Testing Product Market Performance
  10.9.4 BGI Business Overview
  10.9.5 BGI Recent Developments
10.10 Diagnosis
  10.10.1 Diagnosis Basic Information
  10.10.2 Diagnosis Cancer Therapy and Testing Product Overview
  10.10.3 Diagnosis Cancer Therapy and Testing Product Market Performance
  10.10.4 Diagnosis Business Overview
  10.10.5 Diagnosis Recent Developments
10.11 Exact Sciences
  10.11.1 Exact Sciences Basic Information
  10.11.2 Exact Sciences Cancer Therapy and Testing Product Overview
  10.11.3 Exact Sciences Cancer Therapy and Testing Product Market Performance
  10.11.4 Exact Sciences Business Overview
  10.11.5 Exact Sciences Recent Developments
10.12 AstraZeneca
  10.12.1 AstraZeneca Basic Information
  10.12.2 AstraZeneca Cancer Therapy and Testing Product Overview
  10.12.3 AstraZeneca Cancer Therapy and Testing Product Market Performance
  10.12.4 AstraZeneca Business Overview
  10.12.5 AstraZeneca Recent Developments
10.13 Bayer AG
  10.13.1 Bayer AG Basic Information
  10.13.2 Bayer AG Cancer Therapy and Testing Product Overview
  10.13.3 Bayer AG Cancer Therapy and Testing Product Market Performance
  10.13.4 Bayer AG Business Overview
  10.13.5 Bayer AG Recent Developments
10.14 Johnson and Johnson
  10.14.1 Johnson and Johnson Basic Information
  10.14.2 Johnson and Johnson Cancer Therapy and Testing Product Overview
  10.14.3 Johnson and Johnson Cancer Therapy and Testing Product Market Performance
  10.14.4 Johnson and Johnson Business Overview
  10.14.5 Johnson and Johnson Recent Developments
10.15 Pfizer Inc.
  10.15.1 Pfizer Inc. Basic Information
  10.15.2 Pfizer Inc. Cancer Therapy and Testing Product Overview
  10.15.3 Pfizer Inc. Cancer Therapy and Testing Product Market Performance
  10.15.4 Pfizer Inc. Business Overview
  10.15.5 Pfizer Inc. Recent Developments

11 CANCER THERAPY AND TESTING MARKET FORECAST BY REGION

11.1 Global Cancer Therapy and Testing Market Size Forecast
11.2 Global Cancer Therapy and Testing Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Cancer Therapy and Testing Market Size Forecast by Country
  11.2.3 Asia Pacific Cancer Therapy and Testing Market Size Forecast by Region
  11.2.4 South America Cancer Therapy and Testing Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Cancer Therapy and Testing by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global Cancer Therapy and Testing Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of Cancer Therapy and Testing by Type (2026-2035)
  12.1.2 Global Cancer Therapy and Testing Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of Cancer Therapy and Testing by Type (2026-2035)
12.2 Global Cancer Therapy and Testing Market Forecast by Application (2026-2035)
  12.2.1 Global Cancer Therapy and Testing Sales (K Units) Forecast by Application
  12.2.2 Global Cancer Therapy and Testing Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Cancer Therapy and Testing Market Size by Type (M USD)
Table 4. Global Cancer Therapy and Testing Market Size by Application
Table 5. Cancer Therapy and Testing Market Size Comparison by Region (M USD)
Table 6. Global Cancer Therapy and Testing Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Cancer Therapy and Testing Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Cancer Therapy and Testing Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Cancer Therapy and Testing Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Therapy and Testing as of 2025)
Table 11. Global Market Cancer Therapy and Testing Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Cancer Therapy and Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Cancer Therapy and Testing Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Cancer Therapy and Testing Sales by Type (K Units)
Table 27. Global Cancer Therapy and Testing Market Size by Type (M USD)
Table 28. Global Cancer Therapy and Testing Sales (K Units) by Type (2020-2025)
Table 29. Global Cancer Therapy and Testing Sales Market Share by Type (2020-2025)
Table 30. Global Cancer Therapy and Testing Market Size (M USD) by Type (2020-2025)
Table 31. Global Cancer Therapy and Testing Market Share by Type (2020-2025)
Table 32. Global Cancer Therapy and Testing Price (USD/Unit) by Type (2020-2025)
Table 33. Global Cancer Therapy and Testing Sales (K Units) by Application
Table 34. Global Cancer Therapy and Testing Market Size by Application
Table 35. Global Cancer Therapy and Testing Sales by Application (2020-2025) & (K Units)
Table 36. Global Cancer Therapy and Testing Sales Market Share by Application (2020-2025)
Table 37. Global Cancer Therapy and Testing Market Size by Application (2020-2025) & (M USD)
Table 38. Global Cancer Therapy and Testing Market Share by Application (2020-2025)
Table 39. Global Cancer Therapy and Testing Sales Growth Rate by Application (2020-2025)
Table 40. Global Cancer Therapy and Testing Sales by Region (2020-2025) & (K Units)
Table 41. Global Cancer Therapy and Testing Sales Market Share by Region (2020-2025)
Table 42. Global Cancer Therapy and Testing Market Size by Region (2020-2025) & (M USD)
Table 43. Global Cancer Therapy and Testing Market Size by Region (2020-2025)
Table 44. North America Cancer Therapy and Testing Sales by Country (2020-2025) & (K Units)
Table 45. North America Cancer Therapy and Testing Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Cancer Therapy and Testing Sales by Country (2020-2025) & (K Units)
Table 47. Europe Cancer Therapy and Testing Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Cancer Therapy and Testing Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Cancer Therapy and Testing Market Size by Region (2020-2025) & (M USD)
Table 50. South America Cancer Therapy and Testing Sales by Country (2020-2025) & (K Units)
Table 51. South America Cancer Therapy and Testing Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Cancer Therapy and Testing Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Cancer Therapy and Testing Market Size by Region (2020-2025) & (M USD)
Table 54. Global Cancer Therapy and Testing Production (K Units) by Region(2020-2025)
Table 55. Global Cancer Therapy and Testing Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Cancer Therapy and Testing Revenue Market Share by Region (2020-2025)
Table 57. Global Cancer Therapy and Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Cancer Therapy and Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Cancer Therapy and Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Cancer Therapy and Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Cancer Therapy and Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Invitae Basic Information
Table 63. Invitae Cancer Therapy and Testing Product Overview
Table 64. Invitae Cancer Therapy and Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Invitae Business Overview
Table 66. Invitae SWOT Analysis
Table 67. Invitae Recent Developments
Table 68. Foundation Medicine Basic Information
Table 69. Foundation Medicine Cancer Therapy and Testing Product Overview
Table 70. Foundation Medicine Cancer Therapy and Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Foundation Medicine Business Overview
Table 72. Foundation Medicine SWOT Analysis
Table 73. Foundation Medicine Recent Developments
Table 74. Guardant Health Basic Information
Table 75. Guardant Health Cancer Therapy and Testing Product Overview
Table 76. Guardant Health Cancer Therapy and Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Guardant Health Business Overview
Table 78. Guardant Health SWOT Analysis
Table 79. Guardant Health Recent Developments
Table 80. Illumina Basic Information
Table 81. Illumina Cancer Therapy and Testing Product Overview
Table 82. Illumina Cancer Therapy and Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Illumina Business Overview
Table 84. Illumina Recent Developments
Table 85. Sysmex Basic Information
Table 86. Sysmex Cancer Therapy and Testing Product Overview
Table 87. Sysmex Cancer Therapy and Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Sysmex Business Overview
Table 89. Sysmex Recent Developments
Table 90. Abingdon Health Basic Information
Table 91. Abingdon Health Cancer Therapy and Testing Product Overview
Table 92. Abingdon Health Cancer Therapy and Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Abingdon Health Business Overview
Table 94. Abingdon Health Recent Developments
Table 95. Sophia Basic Information
Table 96. Sophia Cancer Therapy and Testing Product Overview
Table 97. Sophia Cancer Therapy and Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Sophia Business Overview
Table 99. Sophia Recent Developments
Table 100. NanoEntek Basic Information
Table 101. NanoEntek Cancer Therapy and Testing Product Overview
Table 102. NanoEntek Cancer Therapy and Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. NanoEntek Business Overview
Table 104. NanoEntek Recent Developments
Table 105. BGI Basic Information
Table 106. BGI Cancer Therapy and Testing Product Overview
Table 107. BGI Cancer Therapy and Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. BGI Business Overview
Table 109. BGI Recent Developments
Table 110. Diagnosis Basic Information
Table 111. Diagnosis Cancer Therapy and Testing Product Overview
Table 112. Diagnosis Cancer Therapy and Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Diagnosis Business Overview
Table 114. Diagnosis Recent Developments
Table 115. Exact Sciences Basic Information
Table 116. Exact Sciences Cancer Therapy and Testing Product Overview
Table 117. Exact Sciences Cancer Therapy and Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Exact Sciences Business Overview
Table 119. Exact Sciences Recent Developments
Table 120. AstraZeneca Basic Information
Table 121. AstraZeneca Cancer Therapy and Testing Product Overview
Table 122. AstraZeneca Cancer Therapy and Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. AstraZeneca Business Overview
Table 124. AstraZeneca Recent Developments
Table 125. Bayer AG Basic Information
Table 126. Bayer AG Cancer Therapy and Testing Product Overview
Table 127. Bayer AG Cancer Therapy and Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Bayer AG Business Overview
Table 129. Bayer AG Recent Developments
Table 130. Johnson and Johnson Basic Information
Table 131. Johnson and Johnson Cancer Therapy and Testing Product Overview
Table 132. Johnson and Johnson Cancer Therapy and Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Johnson and Johnson Business Overview
Table 134. Johnson and Johnson Recent Developments
Table 135. Pfizer Inc. Basic Information
Table 136. Pfizer Inc. Cancer Therapy and Testing Product Overview
Table 137. Pfizer Inc. Cancer Therapy and Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Pfizer Inc. Business Overview
Table 139. Pfizer Inc. Recent Developments
Table 140. Global Cancer Therapy and Testing Sales Forecast by Region (2026-2035) & (K Units)
Table 141. Global Cancer Therapy and Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 142. North America Cancer Therapy and Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 143. North America Cancer Therapy and Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 144. Europe Cancer Therapy and Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 145. Europe Cancer Therapy and Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 146. Asia Pacific Cancer Therapy and Testing Sales Forecast by Region (2026-2035) & (K Units)
Table 147. Asia Pacific Cancer Therapy and Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 148. South America Cancer Therapy and Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 149. South America Cancer Therapy and Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 150. Middle East and Africa Cancer Therapy and Testing Sales Forecast by Country (2026-2035) & (Units)
Table 151. Middle East and Africa Cancer Therapy and Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 152. Global Cancer Therapy and Testing Sales Forecast by Type (2026-2035) & (K Units)
Table 153. Global Cancer Therapy and Testing Market Size Forecast by Type (2026-2035) & (M USD)
Table 154. Global Cancer Therapy and Testing Price Forecast by Type (2026-2035) & (USD/Unit)
Table 155. Global Cancer Therapy and Testing Sales (K Units) Forecast by Application (2026-2035)
Table 156. Global Cancer Therapy and Testing Market Size Forecast by Application (2026-2035) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Cancer Therapy and Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cancer Therapy and Testing Market Size (M USD), 2025-2035
Figure 5. Global Cancer Therapy and Testing Market Size (M USD) (2020-2035)
Figure 6. Global Cancer Therapy and Testing Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cancer Therapy and Testing Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Cancer Therapy and Testing Product Life Cycle
Figure 13. Cancer Therapy and Testing Sales Share by Manufacturers in 2025
Figure 14. Global Cancer Therapy and Testing Revenue Share by Manufacturers in 2025
Figure 15. Cancer Therapy and Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Cancer Therapy and Testing Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Cancer Therapy and Testing Revenue in 2025
Figure 18. Industry Chain Map of Cancer Therapy and Testing
Figure 19. Global Cancer Therapy and Testing Market PEST Analysis
Figure 20. Global Cancer Therapy and Testing Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Cancer Therapy and Testing Market Share by Type
Figure 27. Sales Market Share of Cancer Therapy and Testing by Type (2020-2025)
Figure 28. Sales Market Share of Cancer Therapy and Testing by Type in 2025
Figure 29. Market Share of Cancer Therapy and Testing by Type (2020-2025)
Figure 30. Market Share of Cancer Therapy and Testing by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Cancer Therapy and Testing Market Share by Application
Figure 33. Global Cancer Therapy and Testing Sales Market Share by Application (2020-2025)
Figure 34. Global Cancer Therapy and Testing Sales Market Share by Application in 2025
Figure 35. Global Cancer Therapy and Testing Market Share by Application (2020-2025)
Figure 36. Global Cancer Therapy and Testing Market Share by Application in 2025
Figure 37. Global Cancer Therapy and Testing Sales Growth Rate by Application (2020-2025)
Figure 38. Global Cancer Therapy and Testing Sales Market Share by Region (2020-2025)
Figure 39. Global Cancer Therapy and Testing Market Size by Region (2020-2025)
Figure 40. North America Cancer Therapy and Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Cancer Therapy and Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Cancer Therapy and Testing Sales Market Share by Country in 2024
Figure 43. North America Cancer Therapy and Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Cancer Therapy and Testing Market Size by Country in 2024
Figure 45. U.S. Cancer Therapy and Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Cancer Therapy and Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Cancer Therapy and Testing Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Cancer Therapy and Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Cancer Therapy and Testing Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Cancer Therapy and Testing Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Cancer Therapy and Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Cancer Therapy and Testing Sales Market Share by Country in 2024
Figure 53. Europe Cancer Therapy and Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Cancer Therapy and Testing Market Size by Country in 2024
Figure 55. Germany Cancer Therapy and Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Cancer Therapy and Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Cancer Therapy and Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Cancer Therapy and Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Cancer Therapy and Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Cancer Therapy and Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Cancer Therapy and Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Cancer Therapy and Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Cancer Therapy and Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Cancer Therapy and Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Cancer Therapy and Testing Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Cancer Therapy and Testing Sales Market Share by Region in 2024
Figure 67. Asia Pacific Cancer Therapy and Testing Market Size by Region in 2024
Figure 68. China Cancer Therapy and Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Cancer Therapy and Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Cancer Therapy and Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Cancer Therapy and Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Cancer Therapy and Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Cancer Therapy and Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Cancer Therapy and Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Cancer Therapy and Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Cancer Therapy and Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Cancer Therapy and Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Cancer Therapy and Testing Sales and Growth Rate (K Units)
Figure 79. South America Cancer Therapy and Testing Sales Market Share by Country in 2024
Figure 80. South America Cancer Therapy and Testing Market Size and Growth Rate (M USD)
Figure 81. South America Cancer Therapy and Testing Market Size by Country in 2024
Figure 82. Brazil Cancer Therapy and Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Cancer Therapy and Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Cancer Therapy and Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Cancer Therapy and Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Cancer Therapy and Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Cancer Therapy and Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Cancer Therapy and Testing Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Cancer Therapy and Testing Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Cancer Therapy and Testing Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Cancer Therapy and Testing Market Size by Region in 2024
Figure 92. Saudi Arabia Cancer Therapy and Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Cancer Therapy and Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Cancer Therapy and Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Cancer Therapy and Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Cancer Therapy and Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Cancer Therapy and Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Cancer Therapy and Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Cancer Therapy and Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Cancer Therapy and Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Cancer Therapy and Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Cancer Therapy and Testing Production Market Share by Region (2020-2025)
Figure 103. North America Cancer Therapy and Testing Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Cancer Therapy and Testing Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Cancer Therapy and Testing Production (K Units) Growth Rate (2020-2025)
Figure 106. China Cancer Therapy and Testing Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Cancer Therapy and Testing Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Cancer Therapy and Testing Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Cancer Therapy and Testing Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Cancer Therapy and Testing Market Share Forecast by Type (2026-2035)
Figure 111. Global Cancer Therapy and Testing Sales Forecast by Application (2026-2035)
Figure 112. Global Cancer Therapy and Testing Market Share Forecast by Application (2026-2035)